6-[[5-bromo-6-[3-(trifluoromethyl)pyrrolidin-1-yl]-2-pyridinyl]methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
C17H17BrF3N7 — CID 155792461
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[[5-bromo-6-[3-(trifluoromethyl)pyrrolidin-1-yl]-2-pyridinyl]methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
6-[[5-bromo-6-[3-(trifluoromethyl)pyrrolidin-1-yl]-2-pyridinyl]methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine (PubChem CID 155792461) has the molecular formula C17H17BrF3N7 and a molecular weight of 456.27 g/mol. Its IUPAC name is 6-[[5-bromo-6-[3-(trifluoromethyl)pyrrolidin-1-yl]-2-pyridinyl]methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine.
Molecular Properties
| Compound Name | 6-[[5-bromo-6-[3-(trifluoromethyl)pyrrolidin-1-yl]-2-pyridinyl]methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
|---|---|
| PubChem CID | 155792461 |
| Molecular Formula | C17H17BrF3N7 |
| Molecular Weight | 456.27 g/mol |
| Exact Mass | 455.07 |
| IUPAC Name | 6-[[5-bromo-6-[3-(trifluoromethyl)pyrrolidin-1-yl]-2-pyridinyl]methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
| SMILES | Cc1nc2ncnn2c(N)c1Cc1ccc(Br)c(N2CCC(C(F)(F)F)C2)n1 |
| InChI | InChI=1S/C17H17BrF3N7/c1-9-12(14(22)28-16(25-9)23-8-24-28)6-11-2-3-13(18)15(26-11)27-5-4-10(7-27)17(19,20)21/h2-3,8,10H,4-7,22H2,1H3 |
| InChIKey | JTOSQXCZKIGNDH-UHFFFAOYSA-N |
| XLogP | 3.15 |
| TPSA | 85.23 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.27 |
| LogP ≤ 5 | 3.15 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155792461 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.